» Articles » PMID: 18534037

The Modern Histopathologist: in the Changing Face of Time

Overview
Journal Diagn Pathol
Publisher Biomed Central
Specialty Pathology
Date 2008 Jun 7
PMID 18534037
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular age histopathologist of today is practicing pathology in a totally different scenario than the preceding generations did. Histopathologists stand, as of now, on the cross roads of a traditional 'visible' morphological science and an 'invisible' molecular science. As molecular diagnosis finds more and more applicability in histopathological diagnosis, it is time for the policy makers to reframe the process of accreditation and re-accreditation of the modern histopathologist in context to the rapid changes taking place in this science. Incorporation of such 'molecular' training vis-a-vis information communication technology skills viz. telemedicine and telepathology, digital imaging techniques and photography and a sound knowledge of the economy that the fresh entrant would ultimately become a part of would go a long way to produce the Modern Histopathologist. This review attempts to look at some of these aspects of this rapidly advancing 'art of science.'

Citing Articles

Vulvar cancer incidence and net survival in Sweden 1960 to 2019: A population-based national study.

Moberg L, Sundqvist A, Holmberg E, Dickman P, Borgfeldt C Acta Obstet Gynecol Scand. 2023; 103(3):561-571.

PMID: 38071449 PMC: 10867366. DOI: 10.1111/aogs.14747.


Polarization-based probabilistic discriminative model for quantitative characterization of cancer cells.

Wan J, Dong Y, Xue J, Lin L, Du S, Dong J Biomed Opt Express. 2022; 13(6):3339-3354.

PMID: 35781945 PMC: 9208602. DOI: 10.1364/BOE.456649.


Assessment of tissue pathology using optical polarimetry.

Ali Z, Mahmood T, Shahzad A, Iqbal M, Ahmad I Lasers Med Sci. 2021; 37(3):1907-1919.

PMID: 34689277 DOI: 10.1007/s10103-021-03450-7.


High-fidelity and rapid cellular-level Mueller matrix imaging for tissue identification with unstained sections.

Wang J, Li Y, Cao C, Zhou G, Li L Biomed Opt Express. 2021; 12(8):4745-4758.

PMID: 34513222 PMC: 8407831. DOI: 10.1364/BOE.427614.


Probing variations of fibrous structures during the development of breast ductal carcinoma tissues via Mueller matrix imaging.

Dong Y, Liu S, Shen Y, He H, Ma H Biomed Opt Express. 2020; 11(9):4960-4975.

PMID: 33014593 PMC: 7510861. DOI: 10.1364/BOE.397441.


References
1.
Lyman G, Kuderer N . Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis. Clin Breast Cancer. 2007; 7(5):372-9. DOI: 10.3816/CBC.2006.n.053. View

2.
Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken W . Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res. 2005; 11(16):5730-9. DOI: 10.1158/1078-0432.CCR-04-2225. View

3.
Ma X, Patel R, Wang X, Salunga R, Murage J, Desai R . Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med. 2006; 130(4):465-73. DOI: 10.5858/2006-130-465-MCOHCU. View

4.
Dunn B, Choi H, Almagro U, Recla D, Krupinski E, Weinstein R . Routine surgical telepathology in the Department of Veterans Affairs: experience-related improvements in pathologist performance in 2200 cases. Telemed J. 2000; 5(4):323-37. DOI: 10.1089/107830299311899. View

5.
Weinstein R, Descour M, Liang C, Barker G, Scott K, Richter L . An array microscope for ultrarapid virtual slide processing and telepathology. Design, fabrication, and validation study. Hum Pathol. 2005; 35(11):1303-14. DOI: 10.1016/j.humpath.2004.09.002. View